ATP and cancer immunosurveillance.


Journal

The EMBO journal
ISSN: 1460-2075
Titre abrégé: EMBO J
Pays: England
ID NLM: 8208664

Informations de publication

Date de publication:
01 07 2021
Historique:
revised: 24 03 2021
received: 25 02 2021
accepted: 05 04 2021
pubmed: 15 6 2021
medline: 18 11 2021
entrez: 14 6 2021
Statut: ppublish

Résumé

While intracellular adenosine triphosphate (ATP) occupies a key position in the bioenergetic metabolism of all the cellular compartments that form the tumor microenvironment (TME), extracellular ATP operates as a potent signal transducer. The net effects of purinergic signaling on the biology of the TME depend not only on the specific receptors and cell types involved, but also on the activation status of cis- and trans-regulatory circuitries. As an additional layer of complexity, extracellular ATP is rapidly catabolized by ectonucleotidases, culminating in the accumulation of metabolites that mediate distinct biological effects. Here, we discuss the molecular and cellular mechanisms through which ATP and its degradation products influence cancer immunosurveillance, with a focus on therapeutically targetable circuitries.

Identifiants

pubmed: 34121201
doi: 10.15252/embj.2021108130
pmc: PMC8246257
doi:

Substances chimiques

Adenosine Triphosphate 8L70Q75FXE

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e108130

Informations de copyright

© 2021 The Authors.

Références

Oncoimmunology. 2017 Apr 21;6(6):e1320011
pubmed: 28680754
Cell Death Dis. 2019 Nov 25;10(12):882
pubmed: 31767863
Pathol Res Pract. 2012 Nov 15;208(11):635-41
pubmed: 23089287
Nature. 2020 Apr;580(7801):130-135
pubmed: 32238926
Front Immunol. 2018 Aug 15;9:1899
pubmed: 30158937
Nat Rev Clin Oncol. 2020 Dec;17(12):725-741
pubmed: 32760014
Cell. 2015 Sep 10;162(6):1229-41
pubmed: 26321679
J Clin Invest. 2017 Mar 1;127(3):929-941
pubmed: 28165340
Int J Cancer. 2019 Sep 1;145(5):1414-1422
pubmed: 30664812
Oncoimmunology. 2016 Apr 28;5(7):e1178025
pubmed: 27622030
Cancer Immunol Res. 2020 Apr;8(4):465-478
pubmed: 32047024
Mediators Inflamm. 2019 May 7;2019:4651627
pubmed: 31205451
Nat Rev Immunol. 2019 Dec;19(12):747-760
pubmed: 31409920
Onco Targets Ther. 2020 Oct 14;13:10453-10464
pubmed: 33116625
J Immunol. 2019 Dec 15;203(12):3247-3255
pubmed: 31722989
Cancer Cell. 2016 Jul 11;30(1):147-160
pubmed: 27411589
Biomed Res Int. 2019 Dec 14;2019:4093214
pubmed: 31930120
Nat Med. 2021 Feb;27(2):212-224
pubmed: 33574607
Int Rev Cell Mol Biol. 2019;348:217-262
pubmed: 31810554
Oncoimmunology. 2019 Apr 26;8(8):1601481
pubmed: 31413909
Br J Haematol. 2003 Oct;123(1):66-71
pubmed: 14510944
Cancer Immunol Res. 2020 Nov;8(11):1440-1451
pubmed: 32917658
Blood. 2007 Aug 15;110(4):1225-32
pubmed: 17449799
Nature. 2010 Oct 14;467(7317):863-7
pubmed: 20944749
Nature. 2021 Mar;591(7851):645-651
pubmed: 33589820
Int J Cancer. 2020 Nov 1;147(9):2597-2610
pubmed: 32483858
Int Rev Cell Mol Biol. 2019;347:145-190
pubmed: 31451213
J Cell Mol Med. 2020 Aug;24(15):8674-8686
pubmed: 32643277
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Cancer Immunol Immunother. 2021 Jul;70(7):2009-2021
pubmed: 33416945
Cell Death Differ. 2014 Jan;21(1):79-91
pubmed: 23852373
Nat Immunol. 2002 Nov;3(11):991-8
pubmed: 12407406
Elife. 2019 Feb 08;8:
pubmed: 30735126
J Neurosci. 2019 May 29;39(22):4387-4402
pubmed: 30926752
Science. 2011 Dec 16;334(6062):1573-7
pubmed: 22174255
Eur J Immunol. 2013 Sep;43(9):2430-40
pubmed: 23749427
Nat Rev Clin Oncol. 2017 Feb;14(2):113
pubmed: 28094266
J Exp Med. 2011 Mar 14;208(3):491-503
pubmed: 21383056
PLoS One. 2008 Jul 09;3(7):e2599
pubmed: 18612415
World J Surg Oncol. 2018 Aug 14;16(1):170
pubmed: 30107804
Cancer Immunol Res. 2015 May;3(5):506-17
pubmed: 25672397
Nat Rev Immunol. 2021 Feb;21(2):116-128
pubmed: 32820267
Nat Rev Cancer. 2021 Mar;21(3):162-180
pubmed: 33462499
Oncogene. 2010 Sep 30;29(39):5346-58
pubmed: 20661219
Autophagy. 2020 Jun;16(6):1166-1167
pubmed: 32330398
J Immunol. 2015 Oct 15;195(8):3828-37
pubmed: 26355158
Oncotarget. 2015 Sep 22;6(28):25602-18
pubmed: 26329660
Clin Cancer Res. 2013 Oct 15;19(20):5626-35
pubmed: 23983257
Am J Transl Res. 2014 Jan 15;6(2):129-39
pubmed: 24489992
Oncogene. 2020 Aug;39(35):5795-5810
pubmed: 32724162
Cancer Immunol Res. 2018 Oct;6(10):1136-1149
pubmed: 30131376
J Immunol. 2000 Oct 15;165(8):4615-23
pubmed: 11035104
Int J Cancer. 2018 Sep 15;143(6):1494-1504
pubmed: 29663369
Nat Rev Clin Oncol. 2017 Jul;14(7):399-416
pubmed: 28117416
Int Rev Cell Mol Biol. 2019;348:179-215
pubmed: 31810553
Nat Med. 2009 Oct;15(10):1170-8
pubmed: 19767732
FEBS Lett. 2004 Aug 13;572(1-3):65-8
pubmed: 15304325
Cell Cycle. 2016 Sep;15(17):2265-74
pubmed: 27027731
Int Rev Cell Mol Biol. 2019;342:149-173
pubmed: 30635090
Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1547-52
pubmed: 20080644
Placenta. 2015 Jul;36(7):759-66
pubmed: 25956988
Nat Commun. 2020 Jul 30;11(1):3819
pubmed: 32732875
Gastroenterology. 2010 Sep;139(3):1030-40
pubmed: 20546740
Cancer Immunol Res. 2020 Aug;8(8):1064-1074
pubmed: 32381524
Cancer Res. 2014 Jul 15;74(14):3652-8
pubmed: 24986517
Arch Gynecol Obstet. 2019 Jun;299(6):1737-1746
pubmed: 30941556
Nat Commun. 2020 Jan 24;11(1):515
pubmed: 31980601
J Immunother Cancer. 2020 Nov;8(2):
pubmed: 33177176
J Immunol. 2005 Oct 1;175(7):4383-91
pubmed: 16177079
J Clin Invest. 2002 Oct;110(7):993-1002
pubmed: 12370277
Virchows Arch. 2021 Feb;478(2):209-217
pubmed: 32676968
Cell. 2021 Jan 7;184(1):33-63
pubmed: 33340459
Cancer Discov. 2019 Dec;9(12):1754-1773
pubmed: 31699796
EMBO Rep. 2013 Aug;14(8):686-95
pubmed: 23846313
Life Sci. 2020 Oct 15;259:118389
pubmed: 32898522
Cell Metab. 2016 Nov 8;24(5):657-671
pubmed: 27641098
Int Rev Cell Mol Biol. 2020;354:231-259
pubmed: 32475475
Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):14711-6
pubmed: 23964122
Nat Rev Clin Oncol. 2017 Dec;14(12):717-734
pubmed: 28741618
Cancer Immunol Res. 2014 Jul;2(7):598-605
pubmed: 24990240
J Immunol. 2005 Dec 15;175(12):8260-70
pubmed: 16339566
Cell Rep. 2019 May 21;27(8):2411-2425.e9
pubmed: 31116985
Cancer Immunol Immunother. 2018 Aug;67(8):1271-1284
pubmed: 29923026
Medicine (Baltimore). 2019 May;98(20):e15402
pubmed: 31096436
Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):E9640-E9648
pubmed: 30242135
Nat Rev Immunol. 2019 May;19(5):324-335
pubmed: 30820043
Cancer Cell. 2013 Jul 8;24(1):130-7
pubmed: 23810565
J Immunother Cancer. 2019 Mar 12;7(1):67
pubmed: 30871609
J Biol Chem. 2010 Jun 4;285(23):17406-16
pubmed: 20382737
Cancer Cell. 2016 Sep 12;30(3):391-403
pubmed: 27622332
Int J Cancer. 2014 Mar 15;134(6):1466-73
pubmed: 23982901
PLoS One. 2013 Nov 25;8(11):e81540
pubmed: 24282606
Autophagy. 2017 Sep 2;13(9):1512-1527
pubmed: 28722539
J Immunother Cancer. 2020 May;8(1):
pubmed: 32409420
J Clin Invest. 2020 Mar 2;130(3):1185-1198
pubmed: 31770109
J Clin Invest. 2011 Jun;121(6):2371-82
pubmed: 21537079
Clin Exp Immunol. 2014 Aug;177(2):531-43
pubmed: 24749746
J Biol Chem. 2002 Mar 22;277(12):10482-8
pubmed: 11790776
Cancer Immunol Res. 2020 Mar;8(3):356-367
pubmed: 31992567
Elife. 2021 Jan 07;10:
pubmed: 33410749
J Immunother Cancer. 2020 Dec;8(2):
pubmed: 33361405
Cancer Discov. 2020 Jan;10(1):40-53
pubmed: 31732494
J Biol Chem. 2013 Sep 20;288(38):27571-27583
pubmed: 23918924
Cell Death Dis. 2020 Nov 26;11(11):1015
pubmed: 33243998
Nat Rev Cancer. 2018 Oct;18(10):601-618
pubmed: 30006588
J Immunother Cancer. 2020 Mar;8(1):
pubmed: 32221018
Blood. 2002 Jan 15;99(2):706-8
pubmed: 11781259
EBioMedicine. 2015 Mar;2(3):255-263
pubmed: 25825707
Immunity. 2013 Apr 18;38(4):729-41
pubmed: 23562161
Cancer Res. 2014 Dec 15;74(24):7250-9
pubmed: 25377469
Cancer Immunol Immunother. 2011 Oct;60(10):1405-18
pubmed: 21638125
Oncoimmunology. 2020 Apr 23;9(1):1746138
pubmed: 32363113
Nat Rev Immunol. 2020 Aug;20(8):483-497
pubmed: 32024984
Clin Cancer Res. 2020 May 1;26(9):2176-2187
pubmed: 31953314
Clin Cancer Res. 2016 Jan 1;22(1):158-66
pubmed: 26253870
Cancer Discov. 2021 Jan;11(1):158-175
pubmed: 32847940
Nat Rev Clin Oncol. 2020 Oct;17(10):611-629
pubmed: 32514148
J Biol Chem. 2014 Aug 15;289(33):23189-23199
pubmed: 24962569
Philos Trans R Soc Lond B Biol Sci. 2015 Jul 5;370(1672):
pubmed: 26009770
Leukemia. 2020 Oct;34(10):2708-2721
pubmed: 32269319
N Engl J Med. 2019 May 30;380(22):2104-2115
pubmed: 31141632
Nat Rev Immunol. 2019 Mar;19(3):170-183
pubmed: 30531943
Nat Rev Clin Oncol. 2019 Jun;16(6):356-371
pubmed: 30705439
Glia. 2013 Aug;61(8):1320-30
pubmed: 23832620
Nat Rev Cancer. 2013 Oct;13(10):739-52
pubmed: 24060865
Nat Commun. 2021 Jan 28;12(1):653
pubmed: 33510147
Oncoimmunology. 2016 Jul 11;5(8):e1208875
pubmed: 27622077
Nat Rev Cancer. 2020 Sep;20(9):516-531
pubmed: 32632251
Cell Chem Biol. 2020 Nov 19;27(11):1347-1358.e5
pubmed: 32726585
Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):11091-6
pubmed: 23776241
Cell Cycle. 2013 Jun 15;12(12):1955-63
pubmed: 23708519
Cancer Cell. 2021 Mar 8;39(3):310-345
pubmed: 33338426
Nat Cell Biol. 2018 Mar;20(3):243-251
pubmed: 29476153
Cancer Immunol Immunother. 2012 Jun;61(6):917-26
pubmed: 22116345
Leuk Lymphoma. 2006 Feb;47(2):281-4
pubmed: 16321858
Cancer Res. 2016 Aug 1;76(15):4372-82
pubmed: 27221704
Int J Mol Sci. 2021 Jan 09;22(2):
pubmed: 33435297
Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13132-7
pubmed: 16916931
Biochem Biophys Res Commun. 2014 Oct 10;453(1):101-5
pubmed: 25256743
Autophagy. 2016 May 3;12(5):864-75
pubmed: 26979828
Anticancer Res. 2019 Dec;39(12):6711-6722
pubmed: 31810936
Circ Res. 2006 Nov 10;99(10):1100-8
pubmed: 17038639
J Mol Med (Berl). 2014 Dec;92(12):1283-92
pubmed: 25120128
Int Rev Cell Mol Biol. 2019;348:123-178
pubmed: 31810552
Mediators Inflamm. 2014;2014:509027
pubmed: 24707115
Evid Based Complement Alternat Med. 2020 Mar 23;2020:8475840
pubmed: 32280357
J Immunol. 2020 Jun 1;204(11):2995-3007
pubmed: 32312847
PeerJ. 2021 Feb 3;9:e10814
pubmed: 33604190
Leukemia. 2003 Nov;17(11):2097-100
pubmed: 12931211
J Clin Invest. 2020 Nov 2;130(11):5629-5637
pubmed: 32870821
J Int Med Res. 2020 Nov;48(11):300060520968299
pubmed: 33238786
Nature. 2009 Sep 10;461(7261):282-6
pubmed: 19741708
Cancer Res. 2010 Feb 1;70(3):855-8
pubmed: 20086177
Cell Death Discov. 2020 Nov 24;6(1):129
pubmed: 33298861
Nat Rev Clin Oncol. 2020 Sep;17(9):527-540
pubmed: 32398706
Leukemia. 2021 Jan;35(1):107-118
pubmed: 32203145
Int J Mol Sci. 2018 Apr 18;19(4):
pubmed: 29669994
Nat Med. 2020 Jan;26(1):39-46
pubmed: 31873309
Pancreas. 2013 Jul;42(5):829-35
pubmed: 23429496
Eur J Immunol. 2020 Nov;50(11):1810-1819
pubmed: 32510574
Cancer Biol Ther. 2007 Mar;6(3):426-31
pubmed: 17471030
Am J Physiol Gastrointest Liver Physiol. 2007 Jan;292(1):G223-30
pubmed: 16920697
Ann Oncol. 2018 Apr 1;29(4):1056-1062
pubmed: 29145561
Autophagy. 2015;11(10):1878-90
pubmed: 26506894
Neuro Oncol. 2013 Sep;15(9):1160-72
pubmed: 23737488
Front Immunol. 2016 Aug 29;7:315
pubmed: 27621729
Sci Signal. 2017 Nov 21;10(506):
pubmed: 29162744
Nature. 2021 Mar;591(7848):131-136
pubmed: 33472215
Cancer Res. 2011 Apr 15;71(8):2892-900
pubmed: 21292811
Cancer Res. 2015 Nov 1;75(21):4494-503
pubmed: 26363007
Nat Commun. 2019 Aug 21;10(1):3763
pubmed: 31434891
EMBO Mol Med. 2019 Nov 7;11(11):e10469
pubmed: 31609086
Nat Rev Microbiol. 2014 Jun;12(6):426-37
pubmed: 24830471
Am J Cancer Res. 2014 Mar 01;4(2):172-81
pubmed: 24660106
Lancet. 2002 Dec 14;360(9349):1935-9
pubmed: 12493261
Eur J Immunol. 2011 May;41(5):1231-41
pubmed: 21469131
Nat Med. 2015 Oct;21(10):1128-38
pubmed: 26444637
J Clin Endocrinol Metab. 2009 Feb;94(2):695-8
pubmed: 19017759
Sci Rep. 2018 Apr 10;8(1):5726
pubmed: 29636491
Ann N Y Acad Sci. 2013 May;1284:1-5
pubmed: 23651186
Cancer Immunol Immunother. 2020 Aug;69(8):1565-1576
pubmed: 32306075
Nat Rev Immunol. 2020 Dec;20(12):739-755
pubmed: 32728220
Eur J Haematol. 2004 Apr;72(4):259-63
pubmed: 15089763
Cell Death Dis. 2019 Aug 2;10(8):578
pubmed: 31371700
Nat Rev Cancer. 2013 Jul;13(7):497-510
pubmed: 23760024
Nat Immunol. 2020 Feb;21(2):120-134
pubmed: 31873291
Ann Hematol. 2012 Aug;91(8):1271-9
pubmed: 22349724
Eur J Immunol. 2005 Jan;35(1):31-41
pubmed: 15580656
Cytokine. 2020 Apr 4;130:155082
pubmed: 32259773
Lancet. 2002 Mar 30;359(9312):1114-9
pubmed: 11943260
Asian Pac J Cancer Prev. 2014;15(5):1931-6
pubmed: 24716914
Oncogene. 2019 May;38(19):3636-3650
pubmed: 30655604
J Immunol. 2005 Jan 15;174(2):1073-80
pubmed: 15634932
BMC Cancer. 2017 Feb 15;17(1):135
pubmed: 28202050
Cancer Res. 2018 Jan 1;78(1):115-128
pubmed: 29066514
Int Rev Cell Mol Biol. 2019;344:173-214
pubmed: 30798988
EMBO J. 2021 Jul 1;40(13):e108130
pubmed: 34121201
J Immunol. 2013 Aug 1;191(3):1486-95
pubmed: 23817426
Angiogenesis. 2020 Nov;23(4):599-610
pubmed: 32419057
J Immunol. 2018 Jul 15;201(2):782-791
pubmed: 29802128
Int J Clin Exp Pathol. 2019 Aug 01;12(8):2989-2996
pubmed: 31934136
J Neurosci. 2008 Apr 30;28(18):4702-11
pubmed: 18448647
BMC Cancer. 2020 May 12;20(1):411
pubmed: 32397971
Clin Lymphoma Myeloma Leuk. 2011 Aug;11(4):367-72
pubmed: 21816376
Sci Transl Med. 2018 Sep 19;10(459):
pubmed: 30232229
Nat Immunol. 2020 Oct;21(10):1160-1171
pubmed: 32747819
Cancer Res. 2018 Feb 15;78(4):1003-1016
pubmed: 29229601
Clin Colorectal Cancer. 2019 Mar;18(1):e8-e19
pubmed: 30293873
Eur J Immunol. 2018 Dec;48(12):2042-2054
pubmed: 30259962

Auteurs

Oliver Kepp (O)

Equipe labellisée par la Ligue contre le cancer, Centre de Recherche des Cordeliers, INSERM U1138, Sorbonne Université, Université de Paris, Paris, France.
Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute, Villejuif, France.

Lucillia Bezu (L)

Equipe labellisée par la Ligue contre le cancer, Centre de Recherche des Cordeliers, INSERM U1138, Sorbonne Université, Université de Paris, Paris, France.
Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute, Villejuif, France.

Takahiro Yamazaki (T)

Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.

Francesco Di Virgilio (F)

Department of Medical Sciences, University of Ferrara, Ferrara, Italy.

Mark J Smyth (MJ)

Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Qld, Australia.

Guido Kroemer (G)

Equipe labellisée par la Ligue contre le cancer, Centre de Recherche des Cordeliers, INSERM U1138, Sorbonne Université, Université de Paris, Paris, France.
Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute, Villejuif, France.
Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France.
Suzhou Institute for Systems Medicine, Chinese Academy of Medical Sciences, Suzhou, China.
Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden.

Lorenzo Galluzzi (L)

Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.
Sandra and Edward Meyer Cancer Center, New York, NY, USA.
Caryl and Israel Englander Institute for Precision Medicine, New York, NY, USA.
Department of Dermatology, Yale School of Medicine, New Haven, CT, USA.
Université de Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH